Can Creatine Monohydrate Support Energy and Brain Fog in Long COVID and ME/CFS?

Creatine is a naturally occurring amino acid derivative synthesized primarily in the liver, kidneys, and pancreas from three precursor amino acids: arginine, glycine, and methionine. While the body produces about 1 to 2 grams of creatine daily, it is also absorbed through dietary sources like red meat and seafood. Once synthesized or ingested, creatine is transported through the bloodstream and taken up by tissues with exceptionally high energy demands, predominantly skeletal muscle (which stores about 95% of the body's creatine) and the brain. Inside these cells, creatine plays a fundamental, indispensable role in the regulation and rapid regeneration of adenosine triphosphate (ATP), the universal "energy currency" of all living cells. ATP is composed of an adenine ring, a ribose sugar, and three phosphate groups; the bonds holding these phosphate groups together, known as phosphoanhydride bonds, contain massive amounts of potential energy.

During any form of physical or mental exertion, cells consume ATP by breaking off one of its phosphate molecules, converting it into adenosine diphosphate (ADP) and releasing the stored energy to fuel cellular processes. Because intracellular stores of ATP are extremely limited, they are depleted within just a few seconds of intense cellular activity, necessitating a rapid, highly efficient recycling system. If the cell cannot regenerate ATP quickly enough, cellular function grinds to a halt, leading to immediate muscular fatigue or cognitive stalling. This delicate balance of energy consumption and regeneration is the absolute foundation of human metabolism, and it relies heavily on the presence of adequate intracellular creatine stores to function optimally.

This is where the ATP-Phosphocreatine (ATP-PCr) system, also known as the phosphagen system, becomes critical. Inside the cell, an enzyme called creatine kinase catalyzes a reversible reaction that attaches a high-energy phosphate group to free creatine, converting it into phosphocreatine (PCr). When cellular ATP levels drop and ADP begins to accumulate, phosphocreatine acts as a rapid "temporal energy buffer." It instantly donates its phosphate group back to ADP, regenerating it into fresh ATP without the need for oxygen or the slower, more complex processes of glycolysis and oxidative phosphorylation. This instantaneous regeneration is what allows muscles to contract forcefully and neurons to fire rapidly before the slower metabolic pathways can ramp up production.

Beyond acting as a stationary energy reserve, the phosphocreatine system operates as a highly sophisticated spatial transport network known as the phosphocreatine shuttle. ATP generated deep within the mitochondria does not easily diffuse through the dense cellular cytoplasm to the specific sites of muscle contraction (myofibrils) or neural firing (synapses). Instead, a specific isoform called mitochondrial creatine kinase (CK-MT) transfers the phosphate from newly created ATP to free creatine, yielding PCr. Because PCr is significantly smaller and highly diffusible, it shuttles across the cell to exactly where energy is needed. Once there, cytosolic creatine kinase (CK-MM in muscle, CK-BB in the brain) unloads the phosphate to regenerate ATP on-site, and the resulting free creatine diffuses back to the mitochondria to repeat the cycle.

While creatine's role in skeletal muscle bioenergetics is well-documented, its function in the central nervous system is equally vital, particularly for high-level cognitive processing. The brain accounts for roughly 20% of the body's total resting energy expenditure, despite making up only 2% of total body weight. Neurons rely heavily on the phosphocreatine shuttle to maintain the massive energy gradients required for firing action potentials, synthesizing neurotransmitters, and maintaining synaptic plasticity. Without adequate creatine, the brain simply cannot sustain the rapid energy turnover required for complex thought, memory formation, and sustained attention.

Furthermore, creatine is an osmotically active compound, meaning it directly influences cellular hydration and fluid balance. As creatine is drawn into muscle and brain cells via specific sodium-dependent transporters (such as the SLC6A8 transporter), it pulls water along with it. This increases intracellular water volume, a process known clinically as cell volumization. This cellular swelling is not merely an aesthetic effect or simple "water retention"; the increased osmotic pressure against the cell membrane acts as a mechanical signal that directly stimulates protein synthesis, reduces protein degradation, and enhances overall cellular resilience against metabolic stress. This hydration mechanism is a crucial component of how cells survive and adapt to challenging physiological environments.

In conditions like Long COVID and ME/CFS, the fundamental mechanisms of cellular energy production are often severely disrupted by post-viral cascades. Research indicates that the SARS-CoV-2 virus can cause profound metabolic distress, leading to structural and functional damage within the mitochondria. Studies have identified swollen mitochondria with disrupted cristae and elevated levels of proteins related to abnormal mitochondrial dynamics in Long COVID patients, indicating a severe imbalance in how cells generate and manage energy. This mitochondrial dysfunction means that the slower, oxygen-dependent pathways of ATP production (oxidative phosphorylation) are impaired, forcing the body to rely on less efficient energy systems.

Consequently, the body is forced to rely more heavily on the rapid ATP-PCr system just to meet baseline energy needs, such as walking across a room or holding a conversation. Over time, this constant, excessive demand depletes the body's natural stores of phosphocreatine, leaving cells without their crucial energy buffer. Furthermore, chronic inflammation and oxidative stress generate reactive oxygen species (ROS) that damage the delicate mitochondrial membranes, further impairing the electron transport chain. This creates a vicious cycle where damaged mitochondria cannot produce enough ATP, the phosphocreatine system becomes exhausted trying to compensate, and the patient experiences the profound, crushing fatigue that characterizes these post-viral conditions.

The neurological symptoms of ME/CFS and Long COVID, often described as "brain fog," are increasingly recognized as manifestations of a localized brain energy crisis. Magnetic resonance spectroscopy (MRS) studies have revealed altered metabolism and significantly reduced tissue creatine levels in the brains of patients suffering from post-viral fatigue syndromes. When the brain's phosphocreatine stores are depleted, neurons cannot rapidly regenerate the ATP required for sustained cognitive tasks. This neuro-metabolic failure leads directly to difficulties with concentration, memory recall, word-finding, and processing speed, leaving patients feeling as though they are thinking through thick mud.

This severe energy deficit also contributes directly to post-exertional malaise (PEM), a hallmark symptom where patients experience a severe, delayed exacerbation of symptoms following even minor physical or mental exertion. As detailed in our blog on how early overexertion can prolong and worsen Long COVID symptoms, pushing through this energy deficit without adequate cellular reserves can trigger a vicious cycle of metabolic crash. When the brain and muscles run completely out of ATP and phosphocreatine, cells are forced into anaerobic metabolism, generating high levels of lactic acid and triggering widespread inflammatory cascades that can take days or weeks to resolve.

For patients with dysautonomia and Postural Orthostatic Tachycardia Syndrome (POTS), the autonomic nervous system is in a constant, exhausting state of overdrive. The body struggles to regulate heart rate, blood pressure, and blood vessel constriction, particularly upon standing. This autonomic dysregulation requires immense amounts of cellular energy as the body constantly attempts to achieve homeostasis in the face of erratic neurological signaling. The hyperadrenergic state often seen in POTS means that adrenaline and noradrenaline are constantly flooding the system, keeping the body in a perpetual "fight or flight" response that rapidly burns through available ATP and phosphocreatine stores.

Furthermore, patients with POTS often experience impaired venous return, where blood pools in the lower extremities due to poor vascular tone. The body relies on the "skeletal muscle pump"—the rhythmic contraction of leg and core muscles—to manually push blood back up to the heart and brain against gravity. However, the profound cellular exhaustion and muscle weakness associated with dysautonomia make it incredibly difficult to maintain this muscular scaffolding. The depletion of intracellular creatine not only robs the muscles of the strength needed to support circulation but also compromises the intracellular hydration necessary for maintaining stable cellular function amidst the chaos of autonomic dysfunction.

Supplementing with creatine monohydrate directly addresses the bioenergetic deficits observed in complex chronic illnesses by expanding the intracellular pool of phosphocreatine. By saturating muscle and brain cells with exogenous creatine, patients can increase their resting total creatine concentrations by 20% to 40%. This expanded reservoir allows the phosphocreatine shuttle to operate at optimal capacity, rapidly regenerating ATP during periods of physical or cognitive demand. For individuals with Long COVID or ME/CFS, this means the cells have a significantly more robust "temporal energy buffer" to rely on, reducing the immediate strain on damaged or dysfunctional mitochondria.

By improving the efficiency of ATP recycling, creatine supplementation can help raise a patient's baseline stamina and delay the onset of neuromuscular fatigue. During physical activity, the breakdown of ATP normally leads to an accumulation of hydrogen ions, which lowers cellular pH and causes the burning sensation associated with muscle fatigue. Because the creatine kinase reaction consumes a hydrogen ion when it regenerates ATP from phosphocreatine, increased intracellular creatine actually acts as an intracellular buffer, reducing lactic acid accumulation. This mechanism helps increase a patient's tolerance for daily activities without immediately triggering the severe metabolic crashes associated with post-exertional malaise.

Beyond physical stamina, creatine supplementation offers profound neuroprotective benefits that directly target the cognitive dysfunction often experienced by patients. Because creatine can cross the blood-brain barrier via specific transporters, exogenous supplementation successfully elevates creatine concentrations in key cortical areas, such as the pregenual anterior cingulate cortex and the dorsolateral prefrontal cortex. This increased neural energy capacity helps supply the high metabolic demand required for sustained cognitive tasks, effectively helping to clear the "brain fog" that plagues so many. To understand more about these neurological symptoms, explore our guide on what “brain fog” and cognitive dysfunction look like in Long COVID.

Furthermore, creatine possesses mild antioxidant properties that may help mitigate the chronic, low-grade neuroinflammation and oxidative stress frequently observed in post-viral syndromes. Research suggests that creatine helps stabilize the mitochondrial permeability transition pore (mPTP), preventing it from opening and releasing pro-apoptotic (cell death) factors during times of severe cellular stress. By stabilizing cellular energy, reducing oxidative damage, and protecting mitochondrial integrity, creatine supports overall brain health, improves processing speed, and helps restore the mental clarity necessary for navigating the complexities of chronic illness management.

For patients managing POTS and dysautonomia, creatine offers unique, multifaceted support. While not a direct pharmacological treatment for autonomic dysfunction, creatine enhances muscle mass, strength, and endurance. This is crucial for building the "muscular scaffolding" in the legs and core required to manually improve venous return and counteract blood pooling upon standing. Stronger leg muscles provide a more effective skeletal muscle pump, which can significantly reduce the orthostatic tachycardia (rapid heart rate) that occurs when the heart has to work overtime to pump pooled blood back to the brain.

Additionally, creatine's role as an osmotically active compound provides vital cellular hydration benefits. As creatine draws water into the muscle cells, it increases intracellular water volume, which has been shown to aid thermoregulation and reduce exercising heart rates in hot or humid conditions—frequent triggers for POTS episodes. Furthermore, the absorption of creatine into cells is mediated by sodium-dependent transporters. When paired with the high-sodium diets typically prescribed for POTS, creatine creates a synergistic effect: the sodium expands extracellular blood volume to prevent fainting, while the creatine ensures optimal intracellular hydration and cellular resilience against autonomic stress.

By restoring cellular energy pathways, supporting intracellular hydration, and protecting mitochondrial function, creatine monohydrate may help alleviate several debilitating symptoms associated with chronic invisible illnesses. Here is a breakdown of the specific symptoms creatine targets and the mechanisms behind its efficacy:

When selecting a creatine supplement, the scientific consensus remains heavily in favor of creatine monohydrate. While the supplement industry frequently markets "new and improved" forms like creatine hydrochloride (HCl), ethyl ester, or pyruvate, there is no robust clinical evidence showing they are more effective at increasing tissue creatine content than standard monohydrate. Thorne’s Creatine Monohydrate utilizes a highly researched, micronized form of the compound. Micronization is a mechanical process that reduces the particle size of the powder by about 20 times. While this does not change the compound's fundamental bioavailability—which is already nearly 100% when fully dissolved—it vastly improves its aqueous solubility.

Because micronized creatine particles are so small, they mix smoothly into liquids without leaving a gritty, sandy residue at the bottom of the glass. This makes the supplement significantly gentler on the digestive system and reduces the likelihood of gastrointestinal discomfort, such as bloating, cramping, or nausea. This improved tolerability is particularly important for patients with sensitive guts, irritable bowel syndrome (IBS), or mast cell activation syndrome (MCAS). Furthermore, Thorne's product is NSF Certified for Sport®, ensuring it is rigorously third-party tested for purity, label compliance, and the absolute absence of banned substances, heavy metals, or hidden contaminants.

The standard dosing protocol for creatine in sports nutrition involves a "loading phase" of 20 grams per day for 5-7 days, followed by a "maintenance phase" of 3-5 grams daily. However, for patients with chronic illnesses like ME/CFS or Long COVID, a more gradual, conservative approach is often recommended to minimize any potential gastrointestinal distress or sudden fluid shifts. Many practitioners suggest skipping the aggressive loading phase entirely and simply starting with a steady dose of 3 to 5 grams daily. Over the course of 3 to 4 weeks, this steady dosing will fully saturate muscle and brain creatine stores just as effectively as a rapid loading phase, but with a much lower risk of side effects.

In some clinical trials targeting severe post-viral fatigue and ME/CFS, therapeutic doses ranging from 8 to 16 grams per day have been utilized to effectively offset deep tissue deficiencies and ensure adequate transport across the blood-brain barrier. If pursuing a higher therapeutic dose, it is crucial to divide the intake into smaller 3-4 gram servings taken throughout the day, rather than one massive dose, to maximize absorption via the SLC6A8 transporters. It is imperative to work closely with a healthcare provider to determine the optimal dose for your specific metabolic needs, symptom severity, and baseline kidney function.

The relationship between creatine and hydration is a critical variable, especially for patients with dysautonomia or POTS. Because creatine actively redirects water into the cells (intracellular hydration), it drastically increases the body's overall fluid demand. If a POTS patient takes creatine without simultaneously increasing their intake of water and electrolytes, they risk reducing their intravascular blood volume (the fluid circulating within the blood vessels). This reduction in blood volume can inadvertently trigger or worsen POTS symptoms, leading to increased tachycardia, dizziness, or fainting episodes.

To maximize orthostatic tolerance and safely leverage creatine's benefits, POTS patients must consume creatine alongside their prescribed high-sodium hydration multipliers. This synergistic approach ensures that both fluid compartments are supported: the sodium expands extracellular blood volume to maintain blood pressure and prevent fainting, while the creatine ensures optimal intracellular hydration and cellular resilience. Always dissolve creatine fully in 12 to 16 ounces of an isotonic or electrolyte-rich beverage to facilitate optimal absorption and prevent any osmotic drawing of water into the gut, which can cause diarrhea.

The timing of creatine ingestion is flexible, though research suggests taking it post-workout or alongside a meal may offer slight absorption benefits. Consuming creatine with a source of carbohydrates or protein triggers a mild insulin response. Insulin acts as a transport mechanism that actively helps drive the creatine out of the bloodstream and into the muscle cells, maximizing tissue saturation. For patients practicing pacing, taking creatine with a balanced meal during the most active part of their day can help ensure the energy buffers are fully stocked when needed most.

Regarding interactions, patients should be mindful of caffeine consumption. While occasional caffeine use does not negate creatine's benefits, chronic daily co-ingestion of high doses of caffeine and creatine may overwhelm cellular calcium regulation mechanisms. Creatine helps promote calcium clearance for muscle relaxation, while caffeine stimulates calcium release from the sarcoplasmic reticulum to force muscle contraction; taking them together constantly can blunt creatine's efficacy. Furthermore, mixing the two can significantly increase the risk of gastrointestinal upset. If you consume caffeine, it is highly recommended to space it at least 4 to 5 hours apart from your creatine dose. As always, consult your healthcare provider before starting creatine, especially if you have pre-existing kidney conditions, as creatine metabolism naturally elevates serum creatinine levels on standard lab tests.

Creatine supplementation is rapidly emerging as a highly promising, low-cost therapeutic intervention in the clinical literature for post-viral syndromes. A landmark 2023 randomized, double-blind, placebo-controlled trial published in Food Science & Nutrition evaluated the efficacy of 4 grams of dietary creatine monohydrate per day in patients suffering from moderate-to-severe Long COVID fatigue. The results were striking: at the 3-month mark, the creatine group experienced a significant reduction in general fatigue compared to their baseline. Most notably, patients reported a 77.8% drop in concentration difficulties, and by the 6-month follow-up, brain fog had completely resolved in the creatine group, representing a massive clinical effect size (Cohen's d = 2.46).

Building on this success, a subsequent 2024 trial published in the Journal of Nutritional Science and Vitaminology investigated whether combining creatine with a transport mechanism would enhance its efficacy. Researchers found that administering 8 grams of creatine with 3 grams of glucose daily over eight weeks resulted in substantial reductions in general malaise, body aches, and breathing difficulties. Crucially, MRI brain scans confirmed that the administration of creatine successfully elevated creatine levels in key cortical areas compared to the placebo group, providing objective biological evidence that the supplement was reaching the brain and addressing the localized energy crisis.

The bioenergetic benefits of creatine extend deeply into ME/CFS, a condition historically linked to profound, systemic mitochondrial dysfunction. A groundbreaking 2024 feasibility study published in Nutrients utilized Magnetic Resonance Spectroscopy (MRS) at 3 Tesla to track real-time brain changes in ME/CFS patients taking a high therapeutic dose of 16 grams of creatine daily for 6 weeks. The advanced imaging revealed that creatine successfully crossed the blood-brain barrier, significantly increasing creatine concentrations by 8.3% in the pregenual anterior cingulate cortex and by 2.9% in the dorsolateral prefrontal cortex.

Clinically, this measurable increase in brain energy translated to a statistically significant decrease in overall fatigue, improved peripheral handgrip strength, and faster cognitive reaction times as measured by the Stroop test. Importantly, the researchers found a direct, positive correlation between the increase in brain creatine levels and the improvement in cognitive function, strongly suggesting that restoring the phosphocreatine shuttle directly alleviates brain fog. Furthermore, the high 16g/day dose was extremely well-tolerated, with zero participants dropping out due to adverse side effects, highlighting its safety profile for this sensitive patient population.

The initial positive findings have sparked larger-scale institutional research into how cellular energy buffers can mitigate specific chronic illness symptoms. Current ongoing trials, such as those exploring the therapeutic effects of creatine specifically on post-exertional malaise (PEM), are rigorously measuring cardiopulmonary exercise capacity and mitochondrial function via venous blood samples. Recent reviews in the Journal of the International Society of Sports Nutrition highlight that creatine supplementation serves as a promising therapeutic target for post-viral fatigue syndrome (PVFS) by improving tissue bioenergetics, mitigating muscle atrophy from bedrest, and improving clinician-reported outcomes. As the scientific community continues to unravel the complex connections between Long COVID and ME/CFS, compounds that safely restore the ATP-phosphocreatine shuttle will remain at the absolute forefront of metabolic recovery research.

Living with the profound, unpredictable fatigue and cognitive dysfunction of Long COVID, ME/CFS, or dysautonomia is an incredibly frustrating and often isolating journey. It is vital to remember that your symptoms are intensely real, they are rooted in complex physiological and cellular disruptions, and you are not alone in navigating them. While creatine monohydrate offers a scientifically validated, highly promising mechanism for restoring cellular energy and supporting brain health, it is important to maintain realistic expectations. It is not a standalone cure, nor is it a free pass to push through your energy envelope. Rather, it should be viewed as one powerful, foundational tool within a comprehensive, multidisciplinary management strategy.

True recovery and symptom management require a holistic approach that includes aggressive rest, meticulous symptom tracking, autonomic rehabilitation, and strict pacing to avoid the metabolic crashes of post-exertional malaise. By supporting your mitochondria and expanding your cellular energy buffers with high-quality, easily absorbed supplements, you can help raise your baseline stamina, clear the cognitive fog, and improve your overall quality of life. Always consult with your healthcare provider before introducing new supplements to ensure they align with your specific medical history, kidney function, and current treatment protocols.